The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.
iShares Genomics Immnlgy & Hlthcr ETF IDNA
Morningstar’s Analysis IDNA
Will IDNA outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Moderna Inc | 5.80 | 8.2 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 5.56 | 7.9 Mil | Healthcare |
Sarepta Therapeutics Inc | 5.49 | 7.8 Mil | Healthcare |
Merck & Co Inc | 4.42 | 6.3 Mil | Healthcare |
GSK PLC | 4.35 | 6.2 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 4.15 | 5.9 Mil | Healthcare |
Sanofi SA | 3.69 | 5.2 Mil | Healthcare |
Incyte Corp | 3.68 | 5.2 Mil | Healthcare |
Exelixis Inc | 3.38 | 4.8 Mil | Healthcare |
Roche Holding AG | 3.30 | 4.7 Mil | Healthcare |